HR 7658 · 117th Congress
To amend the Federal Food, Drug, and Cosmetic Act to reauthorize the Critical Path Public-Private Partnerships.
This bill extends and increases funding for a program that helps speed up the development of new medicines and medical treatments. The FDA currently runs something called the Critical Path Public-Private Partnerships, which brings together the government, pharmaceutical companies, medical device makers, and other he…
- Sponsor
- O'Halleran, Tom (D-AZ)
- Introduced
- 2022-05-03
- Policy area
- Health
- Latest action
- Referred to the House Committee on Energy and Commerce.
Digging through Congress... 🔍